UBS Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$934M Buy
3,452,797
+729,134
+27% +$217M 0.14% 144
2025
Q4
$899M Sell
2,723,663
-1,839,868
-40% -$624M 0.15% 127
2025
Q3
$1.58B Buy
4,563,531
+158,349
+4% +$47.9M 0.25% 58
2025
Q2
$1.37B Sell
4,405,182
-1,089,486
-20% -$416M 0.24% 64
2025
Q1
$2.88B Buy
5,494,668
+358,350
+7% +$183M 0.53% 17
2024
Q4
$2.6B Sell
5,136,318
-986,770
-16% -$561M 0.48% 17
2024
Q3
$3.58B Sell
6,123,088
-4,659
-0.1% -$2.64M 0.78% 15
2024
Q2
$3.12B Buy
6,127,747
+1,330,052
+28% +$652M 0.77% 15
2024
Q1
$2.37B Buy
4,797,695
+979,408
+26% +$498M 0.59% 17
2023
Q4
$2.01B Buy
3,818,287
+291,491
+8% +$155M 0.6% 17
2023
Q3
$1.78B Sell
3,526,796
-634,288
-15% -$312M 0.61% 16
2023
Q2
$2B Buy
4,161,084
+727,018
+21% +$355M 0.68% 12
2023
Q1
$1.62B Buy
3,434,066
+139,473
+4% +$67.3M 0.59% 19
2022
Q4
$1.75B Buy
3,294,593
+531,784
+19% +$282M 0.65% 15
2022
Q3
$1.4B Sell
2,762,809
-109,538
-4% -$57.6M 0.61% 16
2022
Q2
$1.48B Buy
2,872,347
+147
+0% +$73.8K 0.61% 19
2022
Q1
$1.46B Sell
2,872,200
-188,219
-6% -$90.8M 0.49% 30
2021
Q4
$1.54B Buy
3,060,419
+233,958
+8% +$106M 0.44% 33
2021
Q3
$1.1B Sell
2,826,461
-157,983
-5% -$65.4M 0.35% 49
2021
Q2
$1.2B Sell
2,984,444
-76,423
-2% -$30.5M 0.39% 40
2021
Q1
$1.14B Sell
3,060,867
-294,762
-9% -$102M 0.38% 46
2020
Q4
$1.18B Sell
3,355,629
-166,416
-5% -$55.8M 0.4% 44
2020
Q3
$1.1B Sell
3,522,045
-398,102
-10% -$122M 0.41% 52
2020
Q2
$1.16B Sell
3,920,147
-292,998
-7% -$84M 0.49% 37
2020
Q1
$1.05B Sell
4,213,145
-297,822
-7% -$82M 0.5% 39
2019
Q4
$1.33B Sell
4,510,967
-222,991
-5% -$58.3M 0.46% 35
2019
Q3
$1.03B Sell
4,733,958
-179,720
-4% -$43.4M 0.4% 49
2019
Q2
$1.2B Buy
4,913,678
+81,898
+2% +$19.7M 0.46% 43
2019
Q1
$1.19B Buy
4,831,780
+461,524
+11% +$118M 0.49% 39
2018
Q4
$1.09B Sell
4,370,256
-276,368
-6% -$73M 0.49% 35
2018
Q3
$1.24B Buy
4,646,624
+207,104
+5% +$53.9M 0.49% 32
2018
Q2
$1.09B Buy
4,439,520
+982,145
+28% +$236M 0.47% 36
2018
Q1
$740M Buy
3,457,375
+1,244,181
+56% +$284M 0.32% 66
2017
Q4
$488M Sell
2,213,194
-25,391
-1% -$5.38M 0.2% 127
2017
Q3
$438M Sell
2,238,585
-6,198
-0.3% -$1.2M 0.2% 113
2017
Q2
$416M Buy
2,244,783
+314,395
+16% +$55.1M 0.22% 111
2017
Q1
$317M Buy
1,930,388
+223,661
+13% +$36.6M 0.17% 141
2016
Q4
$273M Buy
1,706,727
+38,776
+2% +$5.79M 0.15% 157
2016
Q3
$234M Buy
1,667,951
+43,449
+3% +$6.09M 0.14% 169
2016
Q2
$229M Sell
1,624,502
-54,951
-3% -$7.33M 0.14% 160
2016
Q1
$216M Sell
1,679,453
-239,347
-12% -$28.3M 0.15% 155
2015
Q4
$226M Buy
1,918,800
+241,578
+14% +$28.2M 0.15% 153
2015
Q3
$195M Sell
1,677,222
-30,229
-2% -$3.62M 0.14% 162
2015
Q2
$208M Sell
1,707,451
-119,993
-7% -$14.2M 0.14% 172
2015
Q1
$216M Buy
1,827,444
+103,055
+6% +$11.4M 0.15% 157
2014
Q4
$174M Buy
+1,724,389
New +$163M 0.12% 187

Other funds holding UNH

UBS Group's UNH Position: Q1 2026 in Review

UBS Group increased its UnitedHealth (UNH) stake by 27% in Q1 2026, buying an estimated $217M and bringing the position to 3,452,797 shares worth $934M. The position accounts for 0.14% of the portfolio, ranked #144.

UBS Group first reported a position in UNH in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.58B in Q3 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • UBS Group held 3,452,797 shares of UnitedHealth worth $934M as of Q1 2026.
  • UBS Group bought 729,134 UnitedHealth shares in Q1 2026, an estimated $217M.
  • UnitedHealth made up 0.14% of UBS Group's portfolio in Q1 2026, its #144 holding.
  • UBS Group first reported a position in UnitedHealth in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's UnitedHealth position peaked at $3.58B in Q3 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.